CD36 and metabolic dysfunction-associated steatotic liver disease: While it is becoming increasingly clearer that a potential relationship between hepatic lipotoxicity and fatty acid translocase CD36 expression and function in liver cells exists, a number of questions on its impact in NAFLD progression will need to be answered in future studies.